Navigation Links
Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
Date:10/30/2008

SAN FRANCISCO, Oct. 30 /PRNewswire-FirstCall/ -- Medizone International, Inc. (Pink Sheets: MZEI) is pleased to announce the formal establishment of a not-for-profit affiliate, the Canadian Foundation for Global Health (CFGH). CFGH was founded under Canadian Federal Law as a not-for-profit Canadian Corporation headquartered in Ottawa, Ontario, Canada. Under the leadership of Dr. Michael E. Shannon, a founding Director and the foundations' newly appointed President, it is anticipated that the foundation will attract a broad spectrum of the most highly qualified scientists, infectious disease specialists and other medical health professionals from diverse fields of interest to serve on its Board of Directors, Science Advisory Board or as Principal Investigators.

Medizone's Board of Directors have adopted a business philosophy of "creating a corporate paradigm in which the corporation's profit follows its' social contribution." The establishment of this foundation fits into that paradigm not only by being positioned to attract the highest quality professionals possible to our research projects, but it is envisioned that as Medizone's products and treatments become ready for market, the foundation may play a vital role as a distribution source for developing countries with varying price breaks depending on the county's needs and the availability of international assistance; we intend to make effort through both the for-profit and the non-profit to make affordable medical solutions as widely available as possible for the people of the planet.

Medizone International, Inc., is a research and development stage company engaged in the development of novel technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pat
'/>"/>

SOURCE Medizone International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
2. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
3. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
4. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
5. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
6. China Yingxia International, Inc. Appoints New Vice President of Finance
7. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
8. Sangui BioTech International, Inc. Files Remaining Reports
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
11. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015  Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC ... of the securities of Orexigen Therapeutics, Inc. ("Orexigen" ... -News).  Such investors are advised to contact ... Eitan Kimelman at info@bgandg.com ... Orexigen and certain of its officers and/or directors ...
(Date:3/6/2015)... SAN DIEGO , March 6, 2015   ... leading company using proprietary taste science technologies to discover, ... beverage, and flavor industries, announced today that John Poyhonen ... Tony Rogers , Senior Vice President and Chief ... and programs, currently scheduled for Wednesday, March 11, at ...
(Date:3/6/2015)... , March 6, 2015   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... Company,s fourth quarter and full year 2014 financial results will ... the Company will host a conference call and live ...
(Date:3/5/2015)... -- Twelve patients today are preparing to participate in a ... Pacific Medical Center (CPMC), a Sutter Health affiliate. ... the largest single-center kidney paired donation chain conducted on ... 44-year history of the CPMC Transplant Center. The two-day ... donor who did not have a specific recipient in ...
Breaking Biology Technology:SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Orexigen Therapeutics, Inc. 2SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE THE 27TH ANNUAL ROTH CONFERENCE 2BioLife Solutions to Report Fourth Quarter and Full Year 2014 Financial Results and Provide Business Update on March 12, 2015 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4
... 31 TurboSonic,Technologies, Inc. (OTC Bulletin Board: TSTA), a ... pollution control technologies, today,announced that the company,s CEO, Edward ... Press Show., The interview gives viewers an overview ... press release., To view the ...
... The Quigley,Corporation (Nasdaq: QGLY ) today reported net ... quarter ended June 30, 2008,compared to $2.2 million reported ... six months ended June 30, 2008, net sales were ... months ended June 30, 2007., 2008 net sales ...
... Grossan, MD (creator of the Hydro-Pulse sinus irrigation device) ... and anti-inflammatories directly into the sinus cavities using a ... for his patients who experience symptoms of sinus infections, ... ...
Cached Biology Technology:[video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.net's 3-Minute Press Show 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 2The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 3The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 4The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 5The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future 6Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 2
(Date:2/5/2015)... 27, 2015   Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... mysteries of modern coral reefs is how they evolved from ... in the record of coral evolution. This evolutionary gap ... and changes in the Earth,s climate between 1 and 2 ... went extinct, and the modern reef corals emerged. To ...
... Bioinformatics Laboratory at the University of Illinois in collaboration ... probe the world of proteins for answers to questions ... formed from chains of amino acids and fold into ... sciences professor Gustavo Caetano-Anolls, very little is known about ...
... a new study carried out at the Norwegian Institute of ... supplements from four weeks before conception to eight weeks into ... birth to children with childhood autism (classic autism). "It ... before conception to eight weeks into pregnancy," states Pl Surn, ...
Cached Biology News:University of Miami geologists to address the mystery of an evolution gap in reef corals 2Untangling life's origins 2Untangling life's origins 3Folic acid lowers risk of autism 2
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide...
This monoclonal antibody recognizes the light chain of human Factor XII and at 100 nM inhibits 50% of Factor XII activity. It may be used in ELISA to detect human Factor XII and in coagulation assay...
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... cells for DNA isolation. Designed ... (includes 96 well plate adapters from ... the entire plate length (max capacity ... be used for soil, microorganisms, animal ...
Biology Products: